Hello everyone, I would like to ask if anyone here, or anyone you know, has experience using ivermectin and...

CholangiocarcinomaNovember 5, 2026Written by Navis AI

Response to Your Question About Ivermectin and Mebendazole for Cholangiocarcinoma

I appreciate you reaching out to the community with this important question. Let me address both parts of your inquiry systematically.

1) Ivermectin and Mebendazole for Cholangiocarcinoma

What I need to tell you upfront: I don't have specific research on ivermectin or mebendazole for cholangiocarcinoma treatment in my current knowledge base of trusted medical guidelines (NCCN, ASCO, NCI, etc.). These medications are not part of the standard treatment protocols outlined in the NCCN Guidelines for Bile Duct Cancers.

What this means: These drugs are not currently recognized as standard-of-care treatments for cholangiocarcinoma by major cancer organizations. This doesn't necessarily mean they don't have potential - it means they haven't been validated through the rigorous clinical trial process that establishes safety and effectiveness for this specific cancer type.

The evidence-based treatments for cholangiocarcinoma that ARE supported by research include:

Tell us what’s going on with cholangiocarcinoma. 2 free answers, then a free account.

Standard Treatment Options (According to NCCN Guidelines):

For unremovable or metastatic cholangiocarcinoma:

  • Preferred therapies: Durvalumab with Gemcitabine and Cisplatin, or Pembrolizumab with Gemcitabine and Cisplatin
  • Other recommended therapies: Various chemotherapy combinations including FOLFOX, Gemcitabine-based regimens, and others
  • Targeted therapies (if specific mutations are present): For FGFR2, IDH1, BRAF V600E, NTRK, or MSI-H/dMMR mutations

For removable disease:

  • Surgery followed by systemic therapy (Capecitabine is preferred after surgery)
  • Clinical trials

2) What You Should Do With This Information

Critical Questions for Your Oncologist:

  1. "Has my tumor been tested for actionable mutations?" (FGFR2, IDH1, BRAF V600E, NTRK, MSI-H/dMMR) - These could qualify you for targeted therapies with proven effectiveness.

  2. "What standard treatment options am I eligible for, and why do you recommend them for my specific case?"

  3. "Are there clinical trials available for cholangiocarcinoma that I should consider?"

  4. "If I'm interested in complementary approaches, how can we discuss them safely alongside standard treatment?"

About Repurposed Drugs Generally:

Some patients explore "repurposed drugs" (medications originally approved for other conditions) as complementary approaches. However:

  • Drug interactions are a serious concern - medications can interfere with chemotherapy effectiveness or increase toxicity
  • Your oncologist MUST know about any medications you're taking, including over-the-counter drugs and supplements
  • Timing matters - some substances can reduce the effectiveness of standard treatments if taken at the wrong time

The Safer Path Forward:

  1. Start with proven treatments - The NCCN Guidelines represent the best available evidence for what works in cholangiocarcinoma

  2. Get comprehensive biomarker testing - According to NCCN Guidelines, your tumor should be tested for mutations that might respond to targeted therapies. This is standard care, not experimental.

  3. Consider clinical trials - These provide access to promising new treatments with medical supervision and monitoring

  4. Discuss any complementary approaches openly - If you're interested in additional therapies, have an honest conversation with your oncology team about potential benefits, risks, and interactions

Summary: Evidence Coverage

Strong Evidence Available:

  • ✅ Standard chemotherapy regimens for cholangiocarcinoma
  • ✅ Targeted therapies for specific mutations
  • ✅ Immunotherapy combinations
  • ✅ Surgical approaches and post-operative care

Limited/No Evidence in Trusted Guidelines:

  • ❌ Ivermectin for cholangiocarcinoma
  • ❌ Mebendazole for cholangiocarcinoma

My Recommendation

Rather than seeking anecdotal experiences with unproven therapies, I'd strongly encourage you to:

  1. Ensure you've received comprehensive biomarker testing - You may be eligible for targeted therapies that have proven effectiveness

  2. Ask about clinical trials - These provide access to cutting-edge treatments with proper medical oversight

  3. Consult with a cholangiocarcinoma specialist - This is a rare cancer, and treatment at a specialized center can make a significant difference. The NCCN Guidelines specifically recommend seeking care at centers with expertise in bile duct cancers.

  4. If considering complementary approaches, work with an integrative oncology specialist who can help you navigate these decisions safely alongside standard treatment

Important Resources

  • NCCN Cancer Centers have expertise in rare cancers like cholangiocarcinoma: NCCN.org/cancercenters
  • Cholangiocarcinoma Foundation: cholangiocarcinoma.org (patient support and information)
  • Clinical trial matching services can help identify trials you may be eligible for

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

I understand the desire to explore all possible options when facing a serious diagnosis. The most important thing is ensuring you're getting the proven treatments that give you the best chance while avoiding approaches that could interfere with effective therapy. Your oncology team should be your partner in these discussions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated November 5, 2026. Informational only — not a substitute for your oncology team.

Question asked:

Hello everyone, I would like to ask if anyone here, or anyone you know, has experience using ivermectin and mebendazole as part of a treatment approach for cholangiocarcinoma (bile duct cancer). If so, could you please share your experience, including any side effects, how well the treatment was tolerated, and whether you noticed any changes in the patient's condition? I would especially appreciate hearing from patients or caregivers who have firsthand experience. Thank you so much for sharing your experiences and helping one another. 🙏

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about Cholangiocarcinoma